Preview

Proceedings of the Kabardino-Balkarian State University

Advanced search

THE INVESTIGATION OF PROPERTIES OF POLYMER MATRICES SOLUTIONS BASED ON HYALURONIC ACID FOR THE DELIVERY OF DIFLUNISAL AND TAFAMIDIS

Abstract

The dynamic viscosity of solutions of polymer matrices based on hyaluronic acid with the addition of diflunisal and tafamidis was investigated. The drug release from the polymer matrix was studied at different concentrations of diflunisal and tafamidis.

About the Authors

Tatiana Gennadievna Batreva
ITMO University
Russian Federation


Julia Eduardovna Generalova
ITMO University
Russian Federation


Peter Petrovich Snetkov
ITMO University
Russian Federation


Svetlana Nikolaevna Morozkina
ITMO University
Russian Federation


Maya Valeryevna Uspenskaya
ITMO University
Russian Federation


References

1. Sekijima Y. Recent progress in the understanding and treatment of transthyretin amyloidosis // Journal of clinical pharmacy and therapeutics. 2014. V. 39, N 3. P. 225–233.

2. Berk J.L., Suhr O.B., Obici L., Sekijima Y., Zeldenrust S.R., Yamashita T. Diflunisal Trial Consortium. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial // JAMA. 2013. V. 310, N 24. P. 2658–2667.

3. Sekijima Y., Dendle M.A., Kelly J.W. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis // Amyloid. 2006. V. 13, N 4. P. 236–249.

4. Waddington Cruz M., Benson M.D. A review of tafamidis for the treatment of transthyretin-related amyloidosis // Neurology and therapy. 2015. V. 4, N 2. P. 61–79.

5. Vasvani S., Kulkarni P., Rawtani D. Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies // In-ternational journal of biological macromolecules. 2020. V. 151. P. 1012–1029.

6. Luo Z., Dai Y., Gao H. Development and application of hyaluronic acid in tumor targeting drug delivery // Acta Pharmaceutica Sinica B. 2019. V. 9, N. 6. P. 1099–1112.

7. Sun Y., Mao S. Applications of hyaluronic acid and its derivatives-based nanoparticles in drug delivery // Polysaccharide Nanoparticles. Elsevier. 2022. P. 281–311.

8. Oyarzun-Ampuero F.A., Rivera-Rodriguez G.R., Alonso M.J., Torres D. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery // European Journal of Pharmaceutical Sciences. 2013. V. 49, N 4. P. 483–490.

9. Gao Y., Cheng X., Wang Z., Wang J., Gao T., Li P., Chen X. Transdermal delivery of 10,11-methy-lenedioxycamptothecin by hyaluronic acid based nanoemulsion for inhibition of keloid fibroblast // Carbohydrate polymers. 2014. V. 112. P. 376–386.

10. Jin Y.J., Ubonvan T., Kim D.D. Hyaluronic acid in drug delivery systems // Journal of Pharmaceutical Investigation. 2010. V. 40. P. 33–43.

11. Widjaja L.K., Bora M., Chan P.N.P.H., Lipik V., Wong T.T., Venkatraman S.S. Hyaluronic acid- based nanocomposite hydrogels for ocular drug delivery applications // Journal of Biomedical Materials Research Part A. 2014. V. 102, N 9. P. 3056–3065.

12. Wan T., Pan W., Long Y., Yu K., Liu S., Ruan W., Xu Y. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities // International journal of nanomedicine. 2017. V. 12. P. 1485.

13. Zhuo F., Abourehab M.A.S., Hussain Z. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Ef-ficient approach to maximize dermal targeting and anti-dermatitis efficacy // Carbohydrate polymers. 2018. V. 197. P. 478–489.

14. Bassi P.F., Volpe A., D'Agostino D., Palermo G., Renier D., Franchini S., Racioppi M. Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder: results of a phase i study // The Journal of urology. 2011. V. 185, N 2. P. 445–449.

15. Essa M.L., Elashkar A.A., Hanafy N.A., Saied E.M., El-Kemary M. Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro // International Journal of Biological Macromolecules. 2022. V. 206. P. 467–480.

16. Gibbs P., Clingan P.R., Ganju V., Strickland A. H., Wong S.S., Tebbutt N.C., Brown T.J. Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial // Cancer chemotherapy and pharmacology. 2011. V. 67, N 1. P. 153–163.

17. Snetkov P.P., Zakharova K.S., Ganziy M.I., Morozkina S.N., Olekhnovich R.O., Uspenskaya M.V. Research of the Physical Properties of Water-Organic Solutions of Hyaluronic Acid // Izvestiya of the Saint Petersburg State Institute of Technology (Technical University). 2020. No. 55. Pp. 16–21.

18. Snetkov P.P., Uspenskaya M.V., Voronov V.S., Olekhnovich R.O. Production of Nanofibers Based on Native Hyaluronic Acid from Water-Organic Solutions by Electroforming // Izvestiya of the Saint Petersburg State Institute of Technology (Technical University). 2019. No. 51. Pp. 47–50.


Review

For citations:


Batreva T.G., Generalova J.E., Snetkov P.P., Morozkina S.N., Uspenskaya M.V. THE INVESTIGATION OF PROPERTIES OF POLYMER MATRICES SOLUTIONS BASED ON HYALURONIC ACID FOR THE DELIVERY OF DIFLUNISAL AND TAFAMIDIS. Proceedings of the Kabardino-Balkarian State University. 2022;12(4):55-62. (In Russ.)

Views: 25

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2221-7789 (Print)